| Product Code: ETC6889574 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Cyprus continues to rely on key exporting countries such as Greece, Sweden, Belgium, Switzerland, and Germany for its blood plasma derivative imports in 2024. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, with strong growth seen over the years. The impressive Compound Annual Growth Rate (CAGR) of 53.44% from 2020 to 2024, along with a notable growth rate of 55.03% from 2023 to 2024, underscores the increasing demand for blood plasma derivatives in Cyprus. This trend suggests a thriving market with significant opportunities for stakeholders in the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Blood Plasma Derivative Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Blood Plasma Derivative Market - Industry Life Cycle |
3.4 Cyprus Blood Plasma Derivative Market - Porter's Five Forces |
3.5 Cyprus Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Cyprus Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Cyprus Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Cyprus Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Blood Plasma Derivative Market Trends |
6 Cyprus Blood Plasma Derivative Market, By Types |
6.1 Cyprus Blood Plasma Derivative Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F |
6.1.5 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F |
6.1.6 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F |
6.1.7 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F |
6.1.8 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Cyprus Blood Plasma Derivative Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.2.4 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F |
6.2.5 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Cyprus Blood Plasma Derivative Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Cyprus Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F |
7 Cyprus Blood Plasma Derivative Market Import-Export Trade Statistics |
7.1 Cyprus Blood Plasma Derivative Market Export to Major Countries |
7.2 Cyprus Blood Plasma Derivative Market Imports from Major Countries |
8 Cyprus Blood Plasma Derivative Market Key Performance Indicators |
9 Cyprus Blood Plasma Derivative Market - Opportunity Assessment |
9.1 Cyprus Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Cyprus Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Cyprus Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Cyprus Blood Plasma Derivative Market - Competitive Landscape |
10.1 Cyprus Blood Plasma Derivative Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here